| Liraglutide and cardiovascular outcomes in type 2 diabetes SP Marso, GH Daniels, K Brown-Frandsen, P Kristensen, JFE Mann, ... New England Journal of Medicine 375 (4), 311-322, 2016 | 7010 | 2016 |
| Semaglutide and cardiovascular outcomes in patients with type 2 diabetes SP Marso, SC Bain, A Consoli, FG Eliaschewitz, E Jódar, LA Leiter, ... New England Journal of Medicine 375 (19), 1834-1844, 2016 | 5208 | 2016 |
| Liraglutide and renal outcomes in type 2 diabetes JFE Mann, DD Ørsted, K Brown-Frandsen, SP Marso, NR Poulter, ... New England Journal of Medicine 377 (9), 839-848, 2017 | 1179 | 2017 |
| PIONEER 1: randomized clinical trial of the efficacy and safety of oral semaglutide monotherapy in comparison with placebo in patients with type 2 diabetes VR Aroda, J Rosenstock, Y Terauchi, Y Altuntas, NM Lalic, ... Diabetes care 42 (9), 1724-1732, 2019 | 311 | 2019 |
| Efficacy and safety of oral semaglutide with flexible dose adjustment versus sitagliptin in type 2 diabetes (PIONEER 7): a multicentre, open-label, randomised, phase 3a trial. BJB Pieber TR, Bode B, Mertens A, Cho YM, Christiansen E, Hertz CL ... Lancet Diabetes Endocrinol 7 (7), 528-539, 2019 | 198 | 2019 |
| Neck circumference, metabolic syndrome and obstructive sleep apnea syndrome; evaluation of possible linkage S Ahbab, HE Ataoğlu, M Tuna, L Karasulu, F Çetin, LÜ Temiz, M Yenigün Medical science monitor: international medical journal of experimental and …, 2013 | 142 | 2013 |
| Procalcitonin: a novel cardiac marker with prognostic value in acute coronary syndrome HE Ataoğlu, F Yilmaz, I Uzunhasan, F Cetin, LÜ Temiz, YE Döventaş, ... Journal of International Medical Research 38 (1), 52-61, 2010 | 59 | 2010 |
| FT3/FT4 ratio predicts non-alcoholic fatty liver disease independent of metabolic parameters in patients with euthyroidism and hypothyroidism FY Gökmen, S Ahbab, HE Ataoğlu, BÇ Türker, F Çetin, F Türker, ... Clinics 71, 221-225, 2016 | 53 | 2016 |
| Significance and usefulness of narrow fragmented QRS complex on 12‐lead electrocardiogram in acute ST‐segment elevation myocardial infarction for prediction of early mortality … B Stavileci, M Cimci, B Ikitimur, HA Barman, S Ozcan, E Ataoglu, R Enar Annals of Noninvasive Electrocardiology 19 (4), 338-344, 2014 | 41 | 2014 |
| The assessment of pulmonary diffusing capacity in diabetes mellitus with regard to microalbuminuria T Saler, G Cakmak, ZA Saglam, E Ataoglu, TY Erdem, M Yenigun Internal Medicine 48 (22), 1939-1943, 2009 | 35 | 2009 |
| Prognostic significance of high free T4 and low free T3 levels in non-thyroidal illness syndrome HE Ataoğlu, S Ahbab, MK Serez, M Yamak, D Kayaş, ET Canbaz, F Çetin, ... European journal of internal medicine 57, 91-95, 2018 | 30 | 2018 |
| Oxidative status and lipid profile in metabolic syndrome: gender differences A Kaya, I Uzunhasan, M Baskurt, A Ozkan, E Ataoglu, B Okcun, Z Yigit Metabolic syndrome and related disorders 8 (1), 53-58, 2010 | 30 | 2010 |
| Causes of acute poisoning in adults: a retrospective study, in a hospital in Istanbul, Turkey ZA Saglam, B Demir, EH Ataoglu, M Yenigun, LU Temiz, T Saler Journal of public health 20, 59-63, 2012 | 21 | 2012 |
| HIV/AIDS Hastalarında HAV lgG Seroprevalansı AÖ Altuntaş, KH Kumbasar, R Korkusuz, HE Ataoğlu, Ö Nazlıcan XI. Ulusal Viral Hepatit Kongre Kitabı. Antalya, 12-15, 2012 | 19 | 2012 |
| The prevalence of metabolic syndrome in different ethnic groups in Turkey B Kumbasar, M Yenigun, HE Ataoglu, F Sar, K Serez, T Turker, S Tamay, ... Journal of International Medical Research 41 (1), 188-199, 2013 | 18 | 2013 |
| Pulmonary functions in patients with subclinical hypothyroidism. G Cakmak, T Saler, ZA Saglam, M Yenigun, E Ataoglu, T Demir, LU Temiz JPMA. The Journal of the Pakistan Medical Association 61 (10), 951-953, 2011 | 17 | 2011 |
| Additional value of carotid artery intima-media thickness in cardiovascular risk assessment by Framingham risk-score in Type 2 diabetes: a retrospective cohort study. HE Ataoglu, T Saler, I Uzunhasan, M Yenigun, Z Yigit, LU Temiz, ... Journal of diabetes 1 (3), 2009 | 16 | 2009 |
| Vitamin D deficiency is a potential risk for blood pressure elevation and the development of hypertension Y Karadeniz, F Özpamuk-Karadeniz, S Ahbab, E Ataoğlu, G Can Medicina 57 (12), 1297, 2021 | 14 | 2021 |
| The correlation of inflammatory markers and plasma vaspin levels in patients with diabetic nephropathy S Karadag, E Sakci, S Uzun, Z Aydin, E Cebeci, A Sumnu, O Ozkan, ... Renal Failure 38 (7), 1044-1049, 2016 | 12 | 2016 |
| From obesity to diabetes M Yenigün, T Türker, HE Ataoğlu, LE Temiz, S Ahbab Haseki Tıp Bülteni 43, 1-12, 2005 | 12 | 2005 |
